UniProtKB/SwissProt variant VAR

Variant information

Variant position:

613

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LP/P [Disclaimer]

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Cysteine (C) to Arginine (R) at position 613 (C613R, p.Cys613Arg).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from medium size and polar (C) to large size and basic (R)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

-3

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In THPH2; Nijkerk.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs1453479152 [ dbSNP | Ensembl ]

Sequence information

Variant position:

613

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

2224

The length of the canonical sequence.

Location on the sequence:

VPESITTLGFCFDDTVQWHF C SVGTQNEILTIHFTGHSFIY

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         VPESITTLGFCFDDTVQWHFCSVGTQNEILTIHFTGHSFIY

Mouse                         VPESISTLGFCFDDTVQWHFCSVGTHDDILTIHFTGHSFIY

Pig                           VPESIPTLGFCFDDTVQWHFCSVRTHDNILTIHFTGHSFIY

Bovine                        VPESIPILGFCFDDTVQWHFCSVGTQNDILTIHFTGHSFIY

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	29 – 2224	Coagulation factor V
Chain	29 – 737	Coagulation factor V heavy chain
Domain	348 – 684	F5/8 type A 2
Domain	536 – 684	Plastocyanin-like 4
Disulfide bond	603 – 684

Literature citations

Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency.
van Wijk R.; Nieuwenhuis K.; van den Berg M.; Huizinga E.G.; van der Meijden B.B.; Kraaijenhagen R.J.; van Solinge W.W.;
Blood 98:358-367(2001)
Cited for: VARIANTS THPH2 ARG-613 AND CYS-1730;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P12259: Variant p.Cys613Arg